Hand and knee osteoarthritis are considered to be clinically and pathogenically different and distinct, but a new study suggests that Heberden's nodes (HNs) can predict MRI‐based knee osteoarthritis (OA) progression.An NIH study of 575 subjects included clinical examination with evaluation of HNs at baseline and knee MRI at baseline and 24‐month.
Dr. John Cush RheumNow
7 years 9 months ago
Tuhina Neogi, MD, PhD, professor of medicine, has been named chief of the section of rheumatology, in the department of medicine at BU School of Medicine (BUSM) and Boston Medical Center (BMC). https://t.co/0HUj0ji40o
Dr. John Cush RheumNow
7 years 9 months ago
FDA has approved a single-injection hyaluronic acid (Durolane – Bioventus) and an ER formulation of the synthetic corticosteroid triamcinolone acetonide (Zilretta – Flexion) for intra-articular (IA) treatment of osteoarthritic knee pain. https://t.co/7rgsflNMVq
Lenore Buckley and Mary Humphrey have published a nice review of glucocorticoid-induced osteoporosis (GIOP) in the NEJM.
Dr. John Cush RheumNow
7 years 9 months ago
Cluster analysis of 157 SAPHO pts shows 3 distinct patterns or types - spinal type (44.6%; spinal, sacral); costal type (33.1%; ribs) and sternoclavicular type (22.3%) disease course was longer in SC type than costal or spinal types (P < 0.001). https://t.co/NI7AylAoZt
JAMA reports that health care advertising costs in the U.S. have almost doubled over the past two decades, surging from $17.7 billion in 1997 to at least $29.9 billion in 2016. (Citation source: https://buff.ly/2Rk8a9Q)
Dr. John Cush RheumNow
7 years 9 months ago
QD Video from RheumNow - these are daily lessons from the arthritis clinic. Here Dr. Cush discusses what to call seronegative inflammatory arthritis. https://t.co/f7LlwUU0aq
Dr. John Cush RheumNow
7 years 9 months ago
QD Video from RheumNow - Dicusssion of statins and myalgias/arthralgias.
https://t.co/zKFZEF6MiL
A current meta-analysis of safety and efficacy of combination bDMARD treatment in RA patients shows that combination treatments increase serious advese event (SAE) risks, and the risk for serious infections in particular.
Dr. John Cush RheumNow
7 years 9 months ago
Medicare claims analysis shows that older ankylosing spondylitis patients have a 2 fold increased risk of THAT and TKA (R R 2.14, 95% CI 1.93–2.38). https://t.co/HVFFQNTmdz
